Literature DB >> 27444738

Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families.

A Tessa1, R Battini2, A Rubegni1, E Storti1, C Marini3, D Galatolo1, R Pasquariello4, F M Santorelli5,6.   

Abstract

BACKGROUND AND
PURPOSE: The term hereditary spastic paraplegia (HSP) covers a spectrum of genetically heterogeneous disorders in which lower limb spasticity is the common clinical feature. Many patients with childhood-onset HSP are mistakenly diagnosed with cerebral palsy (CP).
METHODS: A group of as yet molecularly undiagnosed HSP patients were analyzed using SpastoPlex, a customized target re-sequencing panel able to investigate the coding regions of 72 genes linked to HSP, spastic ataxias or related motor diseases.
RESULTS: Our investigations identified loss-of-function mutations in AP4S1/SPG52 in four children (three families) who had previously received a diagnosis of diplegic/quadriplegic CP. The patients presented spastic paraparesis, mild facial dysmorphisms, moderate-to-severe intellectual disability and severe speech delay. Two patients manifested febrile seizures and childhood-onset focal seizures. In all the patients, brain magnetic resonance imaging (MRI) showed a peculiar hypoplastic posterior corpus callosum, often associated with ventriculomegaly, white matter loss and cerebral atrophy.
CONCLUSION: Adaptor protein 4 (AP-4) deficiency disorders should be suspected in children with spastic paraparesis, cognitive deficit and absent speech accompanied by suggestive MRI features. Seizures might be amongst the clinical manifestations of the syndrome.
© 2016 EAN.

Entities:  

Keywords:  AP4S1; SPG52; cerebral palsy; hereditary spastic paraparesis; next generation sequencing

Mesh:

Substances:

Year:  2016        PMID: 27444738     DOI: 10.1111/ene.13085

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

Review 1.  Clinical and neuroimaging features of autosomal recessive spastic paraplegia 35 (SPG35): case reports, new mutations, and brief literature review.

Authors:  Francesco Mari; Beatrice Berti; Alessandro Romano; Jacopo Baldacci; Riccardo Rizzi; M Grazia Alessandrì; Alessandra Tessa; Elena Procopio; Anna Rubegni; Charles Marques Lourenḉo; Alessandro Simonati; Renzo Guerrini; Filippo Maria Santorelli
Journal:  Neurogenetics       Date:  2018-02-08       Impact factor: 2.660

2.  Clinical and molecular studies in two new cases of ARSACS.

Authors:  Ivana Ricca; Federica Morani; Giacomo Maria Bacci; Claudia Nesti; Roberto Caputo; Alessandra Tessa; Filippo Maria Santorelli
Journal:  Neurogenetics       Date:  2019-01-24       Impact factor: 2.660

3.  Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.

Authors:  Darius Ebrahimi-Fakhari; Julian Teinert; Robert Behne; Miriam Wimmer; Angelica D'Amore; Kathrin Eberhardt; Barbara Brechmann; Marvin Ziegler; Dana M Jensen; Premsai Nagabhyrava; Gregory Geisel; Erin Carmody; Uzma Shamshad; Kira A Dies; Christopher J Yuskaitis; Catherine L Salussolia; Daniel Ebrahimi-Fakhari; Toni S Pearson; Afshin Saffari; Andreas Ziegler; Stefan Kölker; Jens Volkmann; Antje Wiesener; David R Bearden; Shenela Lakhani; Devorah Segal; Anaita Udwadia-Hegde; Andrea Martinuzzi; Jennifer Hirst; Seth Perlman; Yoshihisa Takiyama; Georgia Xiromerisiou; Katharina Vill; William O Walker; Anju Shukla; Rachana Dubey Gupta; Niklas Dahl; Ayse Aksoy; Helene Verhelst; Mauricio R Delgado; Radka Kremlikova Pourova; Abdelrahim A Sadek; Nour M Elkhateeb; Lubov Blumkin; Alejandro J Brea-Fernández; David Dacruz-Álvarez; Thomas Smol; Jamal Ghoumid; Diego Miguel; Constanze Heine; Jan-Ulrich Schlump; Hendrik Langen; Jonathan Baets; Saskia Bulk; Hossein Darvish; Somayeh Bakhtiari; Michael C Kruer; Elizabeth Lim-Melia; Nur Aydinli; Yasemin Alanay; Omnia El-Rashidy; Sheela Nampoothiri; Chirag Patel; Christian Beetz; Peter Bauer; Grace Yoon; Mireille Guillot; Steven P Miller; Thomas Bourinaris; Henry Houlden; Laura Robelin; Mathieu Anheim; Abdullah S Alamri; Adel A H Mahmoud; Soroor Inaloo; Parham Habibzadeh; Mohammad Ali Faghihi; Anna C Jansen; Stefanie Brock; Agathe Roubertie; Basil T Darras; Pankaj B Agrawal; Filippo M Santorelli; Joseph Gleeson; Maha S Zaki; Sarah I Sheikh; James T Bennett; Mustafa Sahin
Journal:  Brain       Date:  2020-10-01       Impact factor: 15.255

4.  AP4S1 splice-site mutation in a case of spastic paraplegia type 52 with polymicrogyria.

Authors:  Susana Carmona; Clara Marecos; Marta Amorim; Ana C Ferreira; Carla Conceição; José Brás; Sofia T Duarte; Rita Guerreiro
Journal:  Neurol Genet       Date:  2018-09-19

5.  Loss of ap4s1 in zebrafish leads to neurodevelopmental defects resembling spastic paraplegia 52.

Authors:  Angelica D'Amore; Alessandra Tessa; Valentina Naef; Maria Teresa Bassi; Andrea Citterio; Romina Romaniello; Gianluca Fichi; Daniele Galatolo; Serena Mero; Roberta Battini; Giulia Bertocci; Jacopo Baldacci; Federico Sicca; Federica Gemignani; Ivana Ricca; Anna Rubegni; Jennifer Hirst; Maria Marchese; Mustafa Sahin; Darius Ebrahimi-Fakhari; Filippo M Santorelli
Journal:  Ann Clin Transl Neurol       Date:  2020-03-25       Impact factor: 4.511

6.  Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia.

Authors:  Irene Sambri; Filomena Massa; Francesca Gullo; Simone Meneghini; Laura Cassina; Michela Carraro; Giorgia Dina; Angelo Quattrini; Lorenzo Patanella; Annamaria Carissimo; Antonella Iuliano; Filippo Santorelli; Franca Codazzi; Fabio Grohovaz; Paolo Bernardi; Andrea Becchetti; Giorgio Casari
Journal:  EBioMedicine       Date:  2020-10-09       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.